Clinical Effectiveness and Cost-Effectiveness of HIV Pre-Exposure Prophylaxis in Men Who Have Sex with Men: Risk Calculators for Real-World Decision-Making

le Chen, Anders, Dowdy, David W.
Foilsithe 2014

Reply to Chen, Song, and Liu

le Hong, Hyejeong, Dowdy, David W
Foilsithe in Clin Infect Dis (2020)

Cost effectiveness of three months of rifapentine and isoniazid for latent tuberculosis in Syrian refugees

le Ilaiwy, Ghassan, Dowdy, David W.
Foilsithe in J Clin Tuberc Other Mycobact Dis (2021)

The persistence of tuberculosis in the age of DOTS: reassessing the effect of case detection

le Dowdy, David W, Chaisson, Richard E
Foilsithe 2009

Author reply

le Dowdy, David W, Chaisson, Richard E
Foilsithe 2009

Post-2015 tuberculosis strategies in a pre-2015 world

le Dowdy, David W., Chaisson, Richard E.
Foilsithe in Int J Tuberc Lung Dis (2013)

Measuring success: The challenge of social protection in helping eliminate tuberculosis

le Shete, Priya B., Dowdy, David W.
Foilsithe in PLoS Med (2017)

Data Needs for Evidence-Based Decisions: A TB Modeler’s “Wish List”

le Dowdy, David W., Dye, Christopher, Cohen, Ted
Foilsithe 2013

Mathematical Modelling and Tuberculosis: Advances in Diagnostics and Novel Therapies

le Zwerling, Alice, Shrestha, Sourya, Dowdy, David W.
Foilsithe in Adv Med (2015)

Serological Testing Versus Other Strategies for Diagnosis of Active Tuberculosis in India: A Cost-Effectiveness Analysis

le Dowdy, David W., Steingart, Karen R., Pai, Madhukar
Foilsithe 2011

Is Passive Diagnosis Enough?: The Impact of Subclinical Disease on Diagnostic Strategies for Tuberculosis

le Dowdy, David W., Basu, Sanjay, Andrews, Jason R.
Foilsithe 2013

Do We Need to Detect Isoniazid Resistance in Addition to Rifampicin Resistance in Diagnostic Tests for Tuberculosis?

le Denkinger, Claudia M., Pai, Madhukar, Dowdy, David W.
Foilsithe 2014

How much is tuberculosis screening worth? Estimating the value of active case finding for tuberculosis in South Africa, China, and India

le Azman, Andrew S, Golub, Jonathan E, Dowdy, David W
Foilsithe in BMC Med (2014)

Costs and Consequences of Using Interferon-γ Release Assays for the Diagnosis of Active Tuberculosis in India

le Little, Kristen M., Pai, Madhukar, Dowdy, David W.
Foilsithe in PLoS One (2015)

Cost-Consequence Analysis of Multimodal Interventions with Environmental Components for Pediatric Asthma in the State of Maryland

le Jassal, Mandeep S., Diette, Gregory B., Dowdy, David W.
Foilsithe in J Asthma (2013)

Expected effects of adopting a 9 month regimen for multidrug-resistant tuberculosis: a population modelling analysis

le Kendall, Emily A, Fojo, Anthony T, Dowdy, David W
Foilsithe in Lancet Respir Med (2017)

The Epidemiological Importance of Subclinical Tuberculosis. A Critical Reappraisal

le Kendall, Emily A., Shrestha, Sourya, Dowdy, David W.
Foilsithe in Am J Respir Crit Care Med (2021)

Cost-Effectiveness of Novel First-Line Therapeutic Regimens for Tuberculosis

le Owens, Jonathan P., Fofana, Mariam O., Dowdy, David W.
Foilsithe 2013

The Impact of Novel Tests for Tuberculosis Depends on the Diagnostic Cascade

le Sun, Amanda Y., Denkinger, Claudia M., Dowdy, David W.
Foilsithe in Eur Respir J (2014)

The burden of transmitted multi-drug resistance among epidemics of tuberculosis: A transmission model

le Kendall, Emily A., Fofana, Mariam O., Dowdy, David W.
Foilsithe in Lancet Respir Med (2015)